In a filing, Aldeyra Therapeutics Inc revealed its Chief Development Officer Machatha Stephen unloaded Company’s shares for reported $75975.0 on Aug 12 ’24. In the deal valued at $4.74 per share,16,041 shares were sold. As a result of this transaction, Machatha Stephen now holds 236,771 shares worth roughly $1.28 million.
Then, Greenberg Bruce sold 10,834 shares, generating $51,313 in total proceeds. Upon selling the shares at $4.74, the insider now owns 126,382 shares.
Before that, Greenberg Bruce bought 10,834 shares. Aldeyra Therapeutics Inc shares valued at $55,253 were divested by the Officer at a price of $5.10 per share.
Oppenheimer upgraded its Aldeyra Therapeutics Inc [ALDX] rating to an Outperform from a a Perform in a research note published recently. H.C. Wainwright started covering the stock on February 08, 2021. It rated ALDX as “a Buy”.
Price Performance Review of ALDX
On Tuesday, Aldeyra Therapeutics Inc [NASDAQ:ALDX] saw its stock fall -3.56% to $5.42. Over the last five days, the stock has lost -8.14%. Aldeyra Therapeutics Inc shares have risen nearly 54.42% since the year began. Nevertheless, the stocks have risen 268.71% over the past one year. While a 52-week high of $6.55 was reached on 09/05/24, a 52-week low of $1.47 was recorded on 03/15/24. SMA at 50 days reached $5.60, while 200 days put it at $4.18.
Levels Of Support And Resistance For ALDX Stock
The 24-hour chart illustrates a support level at 5.29, which if violated will result in even more drops to 5.16. On the upside, there is a resistance level at 5.63. A further resistance level may holdings at 5.85. The Relative Strength Index (RSI) on the 14-day chart is 48.55, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.04, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 65.77%. Stochastics %K at 37.30% indicates the stock is a holding.
How much short interest is there in Aldeyra Therapeutics Inc?
A steep rise in short interest was recorded in Aldeyra Therapeutics Inc stocks on 2024-10-15, growing by 0.43 million shares to a total of 3.4 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.98 million shares. There was a rise of 12.5%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 16, 2020 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $32 price target.
